April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Replenishment of TIMP-2 Significantly Reduces Scleral Collagen Degradation and Axial Myopia in Tree Shrew
Author Affiliations & Notes
  • Hsin-Hua Liu
    Department of Optometry & Vision Sciences, The University of Melbourne, Parkville, Australia
  • Alex Gentle
    Department of Optometry & Vision Sciences, The University of Melbourne, Parkville, Australia
  • Megan S. Kenning
    Department of Optometry & Vision Sciences, The University of Melbourne, Parkville, Australia
  • Neville A. McBrien
    Department of Optometry & Vision Sciences, The University of Melbourne, Parkville, Australia
  • Footnotes
    Commercial Relationships  Hsin-Hua Liu, None; Alex Gentle, None; Megan S. Kenning, None; Neville A. McBrien, None
  • Footnotes
    Support  NH&MRC #454602
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6307. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hsin-Hua Liu, Alex Gentle, Megan S. Kenning, Neville A. McBrien; Replenishment of TIMP-2 Significantly Reduces Scleral Collagen Degradation and Axial Myopia in Tree Shrew. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6307. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Increased degradation of scleral collagen, by the enzyme MMP-2, has been demonstrated during the development of experimental myopia in avian and mammalian models. The present study determined the endogenous regulation pattern of TIMP-2 in the tree shrew sclera during myopia development and investigated the capacity of exogenous TIMP-2 to inhibit both scleral collagen degradation and myopia development.

Methods: : TIMP-2 expression during myopia development was assessed in two groups of tree shrews (n=7 each group), which underwent either 1 or 5 days of monocular form-deprivation to induce myopia. Scleral tissue was collected and assayed for TIMP-2 mRNA using real-time PCR. Two further groups of tree shrews were injected with [3H] proline, a collagen precursor, before undergoing 12 days of monocular form-deprivation with concurrent daily subconjunctival injections of either TIMP-2 (90µl, 125nM) or vehicle delivered to the occluded eye. Scleral tissue was collected and assayed for collagen degradation. Retinoscopy and A-scan ultrasound were used to monitor in vivo ocular biometry changes.

Results: : The development of myopia was associated with reduced TIMP-2 mRNA expression after 1 (-26±14%, p=0.12) and 5 (-47±14%, p=0.01) days of myopia induction. Replenishment of TIMP-2 significantly reduced myopia development by 60% (vehicle -11.9±0.5 D vs TIMP-2 -4.8±0.8 D, p<0.005), due to reduced vitreous chamber elongation (0.25±0.02 mm vs 0.14±0.01 mm, p=0.005). Collagen degradation in TIMP-2-treated sclerae was not significantly different to normal control eyes (+4±5%).

Conclusions: : Myopia development in mammals is associated with reduced expression of TIMP-2, which contributes to increased, MMP-related, degradative activity in the sclera. Replenishment of TIMP-2 significantly reduces the rate of scleral collagen degradation and myopia development in mammals. This has clinical treatment applications for controlling axial myopia in human.

Keywords: myopia • sclera 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×